[Title will be auto-generated]

CURRICULUM VITAE Ina Stephens, M.D. FAAP Updated August 2009 Personal Data Home address

11105 Valley Heights Drive Owings Mills, MD 21117 410­654­1033

Business address

University of Maryland School of Medicine Center for Vaccine Development 685 W. Baltimore Street Baltimore, MD 21201 410­706­1123; 410­706­5328

Date of Birth: Married with four children

10/17/63

Education/Training 1981 ­ 1985 B.A.

Hamilton College, Clinton, New York Major: Theatre and Dance Performing Arts

1985 ­ 1989 M.D.

Bowman Gray School of Medicine of Wake Forest University, Winston­Salem, NC

Post­Doctoral Training 1989 ­ 1990 Internship

Pediatrics, Bowman Gray School of Medicine North Carolina Baptist Hospital, Winston­Salem, NC

1990 ­ 1992 Residency

Pediatrics, Bowman Gray School of Medicine North Carolina Baptist Hospital, Winston­Salem, NC

1991 ­ 1992 Chief Resident Pediatrics, Bowman Gray School of Medicine North Carolina Baptist Hospital, Winston­Salem, NC 1992 ­ 1994 Fellowship

Pediatric Infectious Diseases, Center for Vaccine Development University of Maryland School of Medicine, Baltimore, MD

Professional Experience 1994 – 1996

Associate, Center for Immunization Research, Division of Vaccine Sciences, Department of International Hygiene, Johns Hopkins University School of Hygiene and

Public Health, Baltimore, MD 1994 ­ present

Adjunct Assistant Professor, Division of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore,MD

1996 – 1998

Pediatrician, Pediatrics at Chartley, Reisterstown, MD

1996 ­ 2007

Attending Physician, Pediatric Infectious Diseases and General Pediatrics, Department of Pediatrics, The Children’s Hospital at Sinai, Baltimore, MD

1997 – 2007

Chief, Division of Pediatric Infectious Diseases, Department of Pediatrics, The Children’s Hospital at Sinai, Baltimore, MD

1998 ­ 2007

Pediatric Residency Program Director, Department of Pediatrics, The Children’s Hospital at Sinai, Baltimore, MD

2004 – present

Physician Advisor – Care First Blue Cross Blue Shield Pediatric Infectious Diseases Advisor and Consultant

2007 ­ present Assistant Professor, Pediatric Infectious Diseases and General Pediatrics, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 2007 ­ present Principal Investigator, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD Affiliations: Annapolis Pediatrics, Annapolis, Maryland The Pediatric Center, Frederick, Maryland 2007 – present Program Director, Pediatric Infectious Diseases Fellowship, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 2008 – present Associate Program Director, Pediatrics, University of Maryland School of Medicine, Baltimore, MD 2008­ present Chief, Clinical Pediatric Infectious Diseases service, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 2008 – 2009

Consultant, Meningococcal Advisory Board, Novartis Vaccines

2008 – 2009

Consultant and Physician Advisor, Sanofi Pasteur, Vaccines

2008 – present Chairman, American Academy of Pediatrics ­ Maryland Chapter, Section on Infectious Diseases 2009 – present Consultant and Physician Advisor, Governor’s Advisory Board, Pandemic Influenza and Swine Flu Preparedness, Department of Mental Health and Hygiene, Baltimore, Maryland

2009 – present Chairman, Immunization Commission, State of Maryland

Certification and Licensure July, 1992

State of Maryland License ­ #D43192

October, 1992

American Board of Pediatrics ­ Board certified; Recertified 5/00, 12/06

November, 1994

Pediatric Infectious Diseases ­ Board certified; Recertified 5/01, 12/08

July, 2003

Certified Personal Trainer – Board certified; NASM, NATABC

Honors and Awards 1985 1999

B.A. Magna cum laude Excellence in Teaching Award ­ Pediatric House Staff, The Children's Hospital at Sinai

2003

Excellence in Teaching Award – Pediatric House Staff, The Children's Hospital at Sinai

2009

Excellence in Teaching Award – Pediatric House Staff, University of Maryland Hospital for Sick Children

2009

Commencement Speaker ­ Graduation of Pediatric House Staff, University of Maryland Hospital for Sick Children

National Presentations 2001

National Association of Pediatric Program Directors Meeting, Chair, Forum for Small Pediatric Residency Program Directors

2001

National Association of Pediatric Program Directors Meeting, Evaluation Toolbox

2002

National Association of Pediatric Program Directors Meeting Chair, Forum for Chairmen and Small Pediatric Residency Program Directors, ACGME/APPD Competency Workshop

2003

National Association of Pediatric Program Directors Meeting, Professionalism

2006

Mid­Atlantic Regional Meeting – Focus Group

Association of Pediatric Program Directors Resident Supervisory Seminar: Skills to Take to the Next Level Societies Fellow, American Academy of Pediatrics Member, Pediatric Infectious Disease Society Member, Association of Pediatric Program Directors Member, National Academy of Sports Medicine Member, Section of Infectious Diseases, American Academy of Pediatrics Member, Maryland Chapter ­ American Academy of Pediatrics Committees 1998 – 2007 1998 – 2007 1998 – 2007 1998 – 2007 1998 – 2007 1998 – 2007 1998 – 2007 1998 – 2007 2001 – 2007 2001 – 2007

Chairperson, Pediatrics Curriculum Committee, The Children's Hospital at Sinai Chairperson, Pediatrics Promotions Committee, The Children's Hospital at Sinai Chairperson, Pediatrics Recruitment Committee, The Children's Hospital at Sinai Member, Scholarly Activity Committee, The Children's Hospital at Sinai Member, Graduate Medical Education Committee, Sinai Hospital Member, Continuing Medical Education Committee, Sinai Hospital Member, Infection Control Committee, Sinai Hospital Member, Association of Pediatric Program Directors Member, Graduate Medical Education Resource Sub­Committee, Sinai Hospital Member, Association of Pediatric Program Directors, Task Force on Residency Evaluations 2001 – 2007 Member, Association of Pediatric Program Directors, Task Force: Action Team 2003 – 2007 Co­Chairperson, End­of­Life Committee, The Children’s Hospital at Sinai 2003 – 2007 Member, Scientific Educational Advisory Board, National Academy of Sports Medicine 2004 – 2007 Chairperson, Cultural Diversity Committee, The Children’s Hospital at Sinai 2006­2007 Member, Pediatric Emergency Department, Multi­disciplinary Committee, Sinai Hospital 2007 Member, Medical Executive Committee, Sinai Hospital 2007 – present Member, Pediatric Educational Workforce, University of Maryland School of Medicine 2007 – present Member, Pediatric Education Committee, University of Maryland School of Medicine 2007 – present Member, Executive Committee of the Infection Control Committee, University of Maryland School of Medicine 2007 – present Member, NICU Infection Control Committee, University of Maryland School of Medicine 2007 – present Member, RSV/Respiratory Viral Infections – subcommittee of the Infection Control Committee, University of Maryland School of Medicine 2007 – present Member, Graduate Medical Education Committee, University of Maryland School of Medicine 2008 – present Member, Adult Clinical Vaccine Trials Committee, University of Maryland School of Medicine

2008 – present Chairperson, Maryland Chapter – American Academy of Pediatrics, Section on Infectious Diseases 2009 ­ present Member, Institutional Review Board, University of Maryland, Baltimore Professional Schools.

2009 – present Member, Governor’s Advisory Board, Pandemic Influenza and Swine Flu Preparedness, Department of Mental Health and Hygiene, Baltimore, Maryland.

2009 – present Chairperson, Immunization Commission, State of Maryland.

Research and Field Experience 1985

Santo Domingo, Dominican Republic (Primary Care)

1993 – 1995

Center for Vaccine Development, University of Maryland Evaluation of immunogenicity of the Hepatitis B vaccination in the premature infant

1995 – 1997

Center for Immunization Research – Johns Hopkins Hospital; Pediatrics at Chartley Evaluation of the safety, tolerability, viral shedding and immunogenicity of the recombinant rotavirus vaccine (RotaShield)

1997– 2003

Center for Immunization Research – Johns Hopkins Hospital and Children’s Hospital at Sinai Evaluation of the safety, tolerability, viral shedding and immunogenicity of recombinant live attenuated respiratory syncytial virus, chimeric subgroup A/B (rRsv­A/B) vaccine, rABcp/248/404/1030 in children and infants

2007­present Principal Investigator, Center for Vaccine Development, University of Maryland School of Medicine, Evaluation of the safety, tolerability, viral shedding and immunogenicity of multiple live, inactivated and combination vaccines in the adult and pediatric population.

2008­ present Principal Investigator, University of Maryland School of Medicine, "Incidence of MRSA infections in the NICU and the Effectiveness of Decolonization".

Grant and Contract Support 2001 ­2002

Ray A. Kroc Foundation ­ Awarded $16,000.00 grant for Faculty Development ­ Chair, Joint Faculty Development Symposium with University of MD, Department of Pediatrics

2003 ­ 2005

Ray A. Kroc Foundation ­ Chair, Joint Faculty Development and Resident Supervisory Symposium Symposium with University of MD, Department of Pediatrics

2007­ present Principal Investigator: Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on 5­ Component Acellular Pertussis Vaccine in Infants and Toddlers (M5a10) Direct costs: $135,400 2007 – present

Principal Investigator: A Phase 3, Randomized, Observer­blind, Controlled, Multi­center Study to Evaluate the Lot to Lot Consistency of Novartis Meningococcal ACWY Conjugate Vaccine when One Dose is Administered to Healthy Adolescents 11­18 years of Age and to Compare the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine with that of Licensed Meningococcal ACWY Conjugate Vaccine (Menactra(tm)) when One Dose is Administered to Healthy Subjects 11­55 years of Age (v59p13) Direct costs: $90,000

2007­ present Principal Investigator: CVD Influenza 23000: Open­label Study of Intramuscular Inactivated Influenza a/H5N1 Vaccine in Healthy Children aged 2 years to 10 years (DMID protocol number: 06­0072) 2007­present

Principal Investigator: Safety and Immunogenicity of Adacel (Tdap vaccine) Compared to Daptacel (Dtap vaccine) as fifth dose Booster in Children 4 to 6 years of Age (Sanofi td517)

2007­present Principal Investigator: A Phase 3, Open­Label, randomized, Parallel­Group, Multi­ Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered with Routine Infant Vaccinations to Healthy Infants (V59P14) Direct costs: $180,000 2008 – present

Principal Investigator Immunogenicity of GlaxoSmithKline Biologicals’ MMRV vaccine (208136) vs. ProQuad, when co­administered with hepatitis A and pneumococcal conjugate vaccines to children 12­14 months of age.

Direct costs: $86,000

2008 – present

Principal Investigator

Immunogenicity of GlaxoSmithKline Biologicals’ Neisseria Meningitidis serogroups A, C, W­135, Y­Tetanus Toxoid Conjugate (MENACWY­TT) Vaccine when co­administered with PedvaxHIB as compared to GSK biologicals’ Haemophilus Influenzae Type B and Neisseria Meningitidis serogroups C and Y­Tetanus Toxoid Conjugate Vaccine combine (HIB­ MENACWY­TT) in healthy Toddlers 12­15 months of age.

Direct costs: Approximately $90,000 2008­ present

Principal Investigator Parvovirus CVD 1000 – a phase I/II study of the safety and immunogenicity of a recombinant human parvovirus B­19 vaccine ­ DMID #05­0078

2008­present

Principal Investigator Antibody persistence and booster dose response in subjects who received Menactra (meningococcal groups A,C, Y and W­135) polysaccharide diphtheria toxoid conjugate vaccine three years earlier in study MTA26.

Direct costs: $61,377 from Sanofi Pasteur

2009 – present

Principal Investigator Phase II randomized, observer­blind, multicenter study of GlaxoSmithKline Biological’s combined MMRV versus ProQuad, according to a one dose schedule, both administered subcutaneously at 12­14 months of age, concomitantly with Hepatitis A vaccine and pneumococcal conjugate vaccine.

Direct costs: $86,000

2009 – present

Principal Investigator Phase II randomized, observer blind, controlled, multicenter study to assess immunogenicity and antibody persistence following vaccination with GSK’s candidate combined measles, mumps, and rubella vaccine (MMR) versus M­M­R II as a first dose, administered subcutaneously at 12­15 months of age, concomitantly with hepatitis A vaccine, varicella vaccine and pneumococcal conjugate vaccine but at separate sites.

Direct costs: Approximately $107,350

2009­ present

Principal Investigator A Phase 1/2a, randomized, double­blind, placebo­controlled study to evaluate the safety, tolerability, immunogenicity, and viral shedding of MEDI­559, a live, attenuated intranasal vaccine against respiratory syncytial virus in healthy 1,12 month­old children.

Direct Costs: Approximately $29,315

2009­present

Principal Investigator A Randomized, Double­Blind Trial on the Safety and Immunogenicity of Inactivated Trivalent Influenza Vaccine in Pregnant Women

2009­present

Co ­Investigator A Phase II Study in Infants (≥6 – <36 months), Children (≥36 months – 9 years), and Adolescents (10 – 17 years) to Assess the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Influenza Vaccine Administered at Two Dose Levels

2009­present

Co ­Investigator Effect of Administration of Licensed TIV Vaccine on the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Influenza Vaccine in Previously Primed Infants and Toddlers (≥6 – <36 months), Children (≥36 months – 9 years), and Adolescents (10 – 17 years)

2009­present

Sub­Investigator Effect of Administration of Licensed TIV Vaccine on the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Influenza Vaccine in Healthy Adult and Elderly Populations

2009­present

Sub­Investigator A Phase II Study in Healthy Adult and Elderly Populations to Assess the Safety and Immunogenicity of an Unadjuvanted CSL H1N1 Influenza Vaccine Administered at Two Dose Levels

2009­present

Sub­Investigator A Phase II Study in Healthy Adult and Elderly Populations to Assess the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Influenza Vaccine Administered at Two Dose Levels

2009­present

Sub­Investigator Rapid Research Response to Influenza or Influenza­like Outbreaks

Resident Research Mentoring Children’s Hospital at Sinai 2000

Alicia Morgan­Cooper ­ Retrospective Study of Neurologic Complications of Lyme Disease: The Diagnosis, Therapy, and Effect on Outcome.

2000

Lisa Johnson ­ Lactoferrin Prophylaxis in Neutropenic Patients

2001

Jeffrey Pender ­ Accuracy of Polymerase Chain Reaction in the Detection of Pneumococcal Bacteremia

2002

Lisa Ciotola ­ Diaphragmatic Paralysis in a Neonate with Congenital Cytomegalovirus Infection: Case Report

2002

Jenene Washington ­ What is the common parental knowledge and physician knowledge of alternative medicine in our pediatric population?

2003

Rose Cummings ­ Neonatal Fungal Endocarditis –Case Report

2004

Heather Rhoden ­ Invasive group A Streptococcal Disease: Case Presentation

2004

Oscar Gomez ­ DNA Sequencing Analysis of the Enterotoxigenic Escherichia Coli Longus Pilus Biosynthetic Genes

2004

Leah Scheier ­ Invasive group G Streptococcal Disease: Case Presentation of Sternoclavicular Septic Arthritis

2005

Thais Rubenstein­Rivitz ­ Complement Component 6 Deficiency: Case Report and Literature Review

2005

Cynthia Roldan ­ Central Line Infections at The Children’s Hospital at Sinai

2007 2007

Bernadette Crowder – Case Report: Pneumocystis Carinii Pneumonia and Primary Immunodeficiencies Samori Cummings – Case Report: CA­MRSA Endocarditis and Current Therapy

2006­present Shira Weis – Toothbrushes as Carriers for and Modes of Reinfection with Group A Streptococcus 2006­present Debbie­Ann Shirley – Determining the Efficacy of Prophylactic Fluconazole in Preventing Invasive Fungal Disease in the Premature Infant University of Maryland Hospital for Sick Children Resident Mentoring 2007­present Mary Boyd ­ Determination of Infectious Pathogens in Neonatal Sepsis 2007­present Robert Boughan ­ Surveillance, Prevalence and Decolonization Intervention in CA­MRSA in the NICU, University of Maryland School of Medicine Pediatric Infectious Diseases Fellow Research Mentoring

2007­present Julia Hutter ­ Surveillance, Prevalence and Decolonization Intervention in CA­ MRSA in the NICU, University of Maryland School of Medicine.

Clinical Pediatric Mentoring: 2007­present Cara Marin – MD/PhD student program ­ Longitudinal mentoring for clinical care in pediatrics and pediatric infectious diseases (100 hours).

University of Maryland School of Medicine.

2008­present Amanda Mason– MD/PhD student program ­ Longitudinal mentoring for clinical care in pediatrics and pediatric infectious diseases (100 hours).

University of Maryland School of Medicine 2008­ present Allison Siegel – First­year MD student ­ Longitudinal mentoring for clinical care in pediatrics and pediatric infectious diseases. University of Maryland School of Medicine 2008­present Calvin Williams – MD/PhD student program ­ Longitudinal mentoring for clinical care in pediatrics and pediatric infectious diseases (100 hours).

University of Maryland School of Medicine Administrative Activities 1998 – 2007

Interviewer, Pediatric Residency Program Applicants, The Children’s Hospital at Sinai. Chairperson of recruitment. Interviewed approximately 115 prospective pediatric interns per year.

2001 ­ Program Director, Residency Review Committee – Site Visit. The Children’s Hospital at Sinai. Led program through successful site visit for full re­ accrediation.

2005 ­ Program Director, Residency Review Committee – Site Visit. The Children’s Hospital at Sinai. Led program through successful site visit for full re­accrediation 2005 ­ Chairperson of Internal Residency Program Reviewer for Physical Medicine and Rehabilitation, Sinai Hospital.

2007 ­ Chairperson of Internal Residency Program Reviewer for Physical Medicine and Rehabilitation, Sinai Hospital.

2007 – present Interviewer, Pediatric Residency Program Applicants, University of Maryland School of Medicine. Member of Pediatric Educational Committee.

2007 – present Program Director, Pediatric Infectious Diseases Fellowship, University of Maryland School of Medicine.

Clinical Activities: 1997 – 2007

Chief, Pediatric Infectious Diseases Consultative Service. The Children’s Hospital at Sinai – 50 weeks per year. Involved responsibility for all inpatient and outpatient consultations, teaching of residents and medical students; also involved frequent telephone consultation from providers throughout Maryland and surrounding regions.

1997 – 2007

Attending Physician, Pediatric Inpatient Ward, The Children’s Hospital at Sinai.

Involved direct patient care and directing a team of residents and medical students in the care of all children admitted to the general pediatric ward service.

2007 – present Attending Physician, Pediatric Infectious Diseases Consultative Service.

University of Maryland School of Medicine. Involves responsibility for all inpatient and outpatient consultations, teaching of residents and medical students; also involves frequent telephone consultation from providers throughout Maryland and surrounding regions.

2007 – present Attending Physician, Pediatric Inpatient Ward, University of Maryland School of Medicine. Involves direct patient care and directing a team of residents and medical students in the care of all children admitted to the general pediatric ward service.

Teaching Services: 1998 – 2007

Attending Physician and Pediatric Infectious Diseases Consultation for pediatric residency Morning Report ­ 5 days per week. The Children’s Hospital at Sinai. Involved direct teaching of residents and medical students for all children admitted to inpatient Pediatric ward.

1998 – 2007

Microbiology rounds – 1 hour per month. The Children’s Hospital at Sinai.

Involved teaching resident and medical students on the inpatient Pediatric ward.

2007 – present Lecturer, Medical School second year class course “Host Defenses and Infectious Diseases” – Viral Respiratory Pathogens, University of Maryland School of Medicine, Baltimore, MD 2007 ­ present Attending Physician and Pediatric Infectious Diseases Consultation for pediatric residency Morning Report – weekly conference. University of Maryland Hospital for Sick Children. Involves direct teaching of residents and medical students for children admitted to inpatient Pediatric ward.

2007 – present Board Review ­ Attending Physician and Pediatric Infectious Diseases Consultation for pediatric residency , University of Maryland Hospital for Sick Children. Involves direct teaching of residents and medical students for national board preparation.

2008­ present Resident Remediation – Involves direct supervision of remediation of residents found to be deficient in medical and clinical fund of knowledge.

Supervision and maintenance of individual study plans and schedules.

Invited Grand Rounds and Presentations; Grand Rounds: Grand Rounds: Sinai Hospital – Department of Pediatrics 1998 ­ Cat Scratch Disease 1999 ­ Lyme Disease 2001 ­ Tick borne Illnesses 2001 ­ Osteomyelitis 2002 ­ Judicious Use of Antibiotics 2004 ­ Osteomyelitis – Update 2005 ­ Community Acquired Methicillin Resistant Staphylococcus Aureus 2007 ­ Community Acquired Methicillin Resistant Staphylococcus Aureus ­ Update Grand Rounds: Wake Forest University School of Medicine – Pediatric 1998 ­ Cat Scratch Disease Grand Rounds: Ann Arundel Medical Center ­ Department of Pediatrics 2000 ­ Congenital Infections 2007 – Lyme Disease Grand Rounds: Carroll County General Hospital 2001 ­ Judicious Use of Antibiotics Grand Rounds : Sinai Hospital – Department of Dentistry 2003 ­ Judicious Use of Antibiotics Grand Rounds: Sinai Hospital – Department of Nursing 2006 ­ Community Acquired Methicillin Resistant Staphylococcus Aureus Grand Rounds: Sinai Hospital – Department of Ophthalmology 2007 ­ Orbital Infections Grand Rounds: Franklin Square Hospital – Department of Pediatrics 2007 ­ Tick­Borne Illness Grand Rounds: St. Joseph’s Medical Center – Department of Pediatrics 2007 ­ Community Acquired Methicillin Resistant Staphylococcus Aureus

Grand Rounds: Mercy Medical Center­ Department of Pediatrics 2008 – Community Acquired Methicillin Resistant Staphylococcus Aureus 2009 – Lyme Disease and Other Tick­borne Illnesses Grand Rounds: University of Maryland – Department of Pediatrics 2008 – Community Acquired Methicillin Resistant Staphylococcus Aureus Grand Rounds: University of Maryland – Nurse Practitioner Conference 2009 – Pneumonia and Parapneumonic Effusions Grand Rounds: University of Maryland – Maryland’s Health­Systems Pharmacists 2009 – H1N1 Influenza Update Presentations: Multiple Lectures given for Pfizer/GSK/Abbott – 2000­2004 Judicious Use of Antibiotics Otitis Media/Sinusitis Common Respiratory Infections in Pediatrics Sinai Hospital ­ Town Meeting on Bioterrorism 2003 ­ Panel Expert Parent Education Program Franklin Middle School, Reisterstown, MD 2004 ­ Childhood Obesity Health Fair 2004 – Redemption Christian Fellowship; Keynote Speaker 2004 ­ Childhood Obesity and its Impact on Adult Health Parent Education Program, Baltimore Hebrew Day School 2004 ­ Common Childhood Illnesses and Frequently Asked Questions 2005 ­ Childhood Obesity The 22nd 3­P Conference: “ A Potpourri of Practical Pediatrics 2005 ­ Community Acquired Methicillin Resistant Staphylococcus Aureus Ann Arundel Medical Center 2008 – Immunizations and Your Child University of Maryland ­ Community Outreach CME Program 2009 – H1N1 Immunization Update Pediatric Residency Core Curriculum – Conference Series 1997 – 2007 1­2 lectures given per month, 1 hour in length

Sinai Hospital: Herpes Simplex Infections Pediatric HIV Fungal Infections Fungal Infections – Endemic Mycoses Peds Infectious Diseases ­ Board Review General Pediatric Board Review Hepatitis Infectious Diseases ­ Journal Club Professionalism Osteomyelitis/Septic Joint ­ Part 1 Osteomyelitis ­ Part 2 Infection Control Tick borne Illnesses Congenital Infections Neonatal Infections Respiratory Infections Infectious Gastroenteritis Meningitis Antibiotics –Part 1 Antibiotics – Part 2 Fever without Source: 0­36 months Childhood Obesity Immunizations Part 1 Immunizations Part 2 Otitis Media/Sinusitis Lymphadenitis UTI and Pyelonephritis Fever and Rash Primary Immunodeficiencies Mycobacterium Tuberculosis University of Maryland: Lyme Disease Cat Scratch Fever Herpes Simplex Infections Tick­borne Illnesses Pediatric Board Review Pediatric Infectious Disease Board Review Publications Chapters and Reviews: 1. Stephens Burrows I, Levine MM. Cholera. In text: Gellis and Kagan’s Current Pediatric Therapy. 15th edition, Burg, FD, Ingelfinger, JR, Polin, R, Wald, E. (eds). WB Saunders Co., 1994.

2. Stephens I, Nataro JP. “Inflammatory Enteritis.” In Principles and Practice of Pediatric Infectious Diseases, Long SL, Prober CG, Pickering LK (eds). Churchill Livingstone, 1997.

3. Clements ML, Stephens I. “Influenza Vaccines.” In New Generation Vaccines. Levine MM, Woodrow GC, Kaper JB, Cobon GS (eds). Marcel Dekker, Inc., New York, NY. 1997.

4. Stephens I, Levine MM. Management of Typhoid Fever in Children, Concise Reviews.

Pediatr. Infect. Dis. J. 2002: 157­158.

5. Stephens I, Nataro JP. "Inflammatory Enteritis," In Principles and Practice of Pediatric Infectious Diseases, 2nd Edition. Long SL, Prober CG, Pickering LK (eds). Churchill Livingstone. October 2002.

6. Stephens I. Childhood Obesity­Part 1. National Academy of Sports Medicine, NASM.org, Issue 1, No.5, 2004 7. Stephens I. Childhood Obesity­Part 2. National Academy of Sports Medicine, NASM.org, Issue 1, No. 5, 2004 8. Stephens I, Nataro JP. Prevention of Enteric Diseases, In: Hot Topics in Infection and Immunity in Children. Pub: Kluwer Academic Publishers, New York, NY 2004, pp. 71­79.

9. Stephens I, Nataro JP. Prevention of enteric diseases. Adv Exp Med Biol. 2004;549:71­82 10.Stephens I, Nataro JP. "Inflammatory Enteritis," In Principles and Practice of Pediatric Infectious Diseases, 3rd Edition. Long SL, Prober CG, Pickering LK (eds). Churchill Livingstone. January 2008.

11. Stephens I, Nataro JP. “Travelers’ Diarrhea”, Infections in Medicine. 2008; 25(6):264­8.

12. Stephens I, Nataro JP, Johnson JK. “Molecular Diagnostics of Infectious Diseases”. PREP Audio Program, American Academy of Pediatrics, 2009; In press.

Peer­ Reviewed Publications: 1. Lambert JS, Stephens I, Christy C, Abramwicz JS, Woodkin KA. HIV and syphilis: maternal and fetal considerations. Ped. AIDS and HIV infection: fetus to adolescent.

1995;6:138­144.

2. Losonsky GA, Stephens I, Mahoney F et al. Weight contributes to hepatitis B vaccine immune response. Infect. Dis. Child 1995;8:10.

3. Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulerian S, West DJ, Gewolb IH. Hepatitis B vaccination of Premature Infants: A Reassessment of Current Recommendations for Delayed Immunization. Pediatr 1999;103:1­7.

4. Wenk R, Stephens I. Erythrocyte FyAntigen Phenotyping Helps to Differentiate So­Called Benign Tertian Malarias, Archives of Pathology and Laboratory Medicine. Arch Pathol Lab Med 2000; 124:299­01.

5. Clements­Mann ML, Dudas R, Hoshino Y, Nehring P, Sperber E, Wagner M, Stephens I, Karron R, Deforest A, Kapikian AZ. Safety and immunogenicity of live attenuated quadrivalent human­bovine (UK) reassortant rotavirus vaccine administered with childhood vacines to infants. Vaccine 2001; 19(32):4676­84.

6. Branfoot T, Herzenberg JE, Paley D, Stephens I, Bor N. Life and Limb Threatening Infections: Rare Complications Associated with External Fixation, Clinical Orthopedics and Related Research 2003.

Abstracts: 1. Losonsky GA, Stephens I, Mahoney F et al. Preliminary results evaluating the immunogenicity of hepatitis B vaccination of premature infants starting in the first week of life. Abstract 1752. American Pediatric Society and the Society for Pediatric Research, San Diego,CA 1995.

2. Lovchik J, Oberste M, Hammond P, Stephens I, Blaisdell C. Novel Enterovirus Associated with Hospitalizations for Asthma In Children, Abstract accepted for publication, 2004